Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-008-0428-9.pdf
Reference28 articles.
1. Mano MS, Awada A (2004) Primary chemotherapy for breast cancer: the evidence and the future. Ann Oncol 15:1161–1171. doi: 10.1093/annonc/mdh302
2. Kuerer HM, Newman LA, Smith TL et al (1999) Clinical course of breast cancer patients with complete pathological tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17:460–469
3. Kaufmann M, Hortobagyi GN, Goldhirsch A et al (2006) Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 24:1940–1949. doi: 10.1200/JCO.2005.02.6187
4. Pierga JY, Mouret E, Dieras V et al (2000) Prognostic role of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer. Br J Cancer 83:1480–1487. doi: 10.1054/bjoc.2000.1461
5. Rouzier R, Extra JM, Klijanienko J et al (2002) Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol 20:1304–1310. doi: 10.1200/JCO.20.5.1304
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer;2024-01-25
2. Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial;Breast Cancer Research and Treatment;2024-01-12
3. Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial;2023-05-31
4. Comparison of clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in very young women and older women with breast cancer;2022-10-31
5. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis;International Journal of Cancer;2022-10-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3